Burling Wealth Partners LLC Purchases Shares of 1,119 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Burling Wealth Partners LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 1,119 shares of the medical equipment provider's stock, valued at approximately $584,000.

A number of other institutional investors have also recently made changes to their positions in ISRG. Norges Bank acquired a new position in Intuitive Surgical in the 4th quarter valued at about $2,401,493,000. Proficio Capital Partners LLC grew its position in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after buying an additional 948,902 shares during the last quarter. Capital Research Global Investors raised its position in shares of Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB grew its position in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after acquiring an additional 552,058 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,913 shares of company stock worth $15,981,143 over the last ninety days. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms have weighed in on ISRG. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Leerink Partners increased their price objective on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group upped their price objective on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Stock Performance

ISRG traded down $5.90 on Wednesday, hitting $508.99. The company had a trading volume of 449,933 shares, compared to its average volume of 1,612,916. The stock has a fifty day moving average price of $508.20 and a 200-day moving average price of $533.13. Intuitive Surgical, Inc. has a 12-month low of $367.39 and a 12-month high of $616.00. The stock has a market capitalization of $182.43 billion, a price-to-earnings ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the business earned $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.